AstraZeneca’s share price has fallen a long way on an investigation surrounding its Chinese business. So, do the shares look ...

Henning JW, Brezden-Masley C, Gelmon K, Chia S, Shapera S, McInnis M, Rayson D, Asselah J. Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian ...

Chinese biomedical research is on the cusp of a breakthrough just as the industry starts to face serious headwinds ...

AT A time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

BEIJING: British companies operating in China feel that doing business in the world's second-largest economy has become ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, ...

combined with its cost control history, remain underappreciated." BofA increased its share price target to 370 pence each from 300p and reiterated a 'buy' rating. On Tuesday, Morgan Stanley made IAG a ...

AstraZeneca is a company with a turbulent history but, for now ... perhaps underlining the importance of AZ to the country’s life sciences sector, with both AZ and Pfizer asked to argue for ...

During this trip PM Modi created history by becoming the ... India sent 70,000 doses of the AstraZeneca COVID-19 vaccine to Dominica, helping the country support its Caribbean neighbors.

Australia's COVID-19 response saved countless lives, but it also left hundreds of people believing they were suffering a constellation of strange symptoms from the vaccines. Now they're fighting a ...